{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:49:54Z","timestamp":1794653394503,"version":"4.9.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>One of the major immune checkpoints responsible for immune evasion in cancer cells is the interaction between programmed cell death-1 (PD-1) and its ligand (PD-L1). As human trophoblastic cells display many of the features of malignant cells such as the ability to invade normal tissue including blood vessels and are apparently not eradicated by the host immune system, we undertook the present study to determine whether PD-L1 was upregulated in different types of trophoblastic cells during normal pregnancy and in gestational trophoblastic diseases. Immunohistochemistry using an anti\u2013PD-L1-specific antibody demonstrated that in early and term normal placentas, PD-L1 was highly expressed in syncytiotrophoblast and to a much lower extent in intermediate trophoblastic cells located in the chorion laeve and implantation site. PD-L1 immunoreactivity was undetectable in cytotrophoblastic cells. This staining pattern in normal placenta was recapitulated in various types of gestational trophoblastic disease. PD-L1 was highly expressed by syncytiotrophoblast in complete moles and choriocarcinomas. The intermediate trophoblastic neoplasms, placental site trophoblastic tumors, and epithelioid trophoblastic tumors showed variable PD-L1 immunoreactivity but at a lower intensity than in the neoplastic syncytiotrophoblast in choriocarcinoma. In addition, we observed PD-1-positive lymphocytes located within the implantation site and in trophoblastic tumors. In summary, this study describes a novel mechanism for trophoblastic cells to create a tolerogenic feto-maternal interface by upregulating PD-L1 in syncytiotrophoblast and in intermediate trophoblast. Trophoblastic tumors may also use PD-L1 expression to evade the host immune response thereby promoting their survival.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000305","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:48:31Z","timestamp":1467632911000},"page":"146-153","source":"Crossref","is-referenced-by-count":201,"title":["PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases"],"prefix":"10.1097","volume":"36","author":[{"given":"Emanuela","family":"Veras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/humrep\/den344","article-title":"A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation","volume":"24","author":"Fraccaroli","year":"2009","journal-title":"Hum Reprod"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00000478-200207000-00010","article-title":"HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis","volume":"26","author":"Singer","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.1517724112","article-title":"The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interface","volume":"112","author":"Tilburgs","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.274.5288.792","article-title":"Protection from natural killer cell-mediated lysis by HLA-G expression on target cells","volume":"274","author":"Pazmany","year":"1996","journal-title":"Science"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0897.2006.00420.x","article-title":"Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1","volume":"56","author":"Poehlmann","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.179.8.5211","article-title":"A link between PDL1 and T regulatory cells in fetomaternal tolerance","volume":"179","author":"Habicht","year":"2007","journal-title":"J Immunol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/11.8.1351","article-title":"HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes","volume":"11","author":"Le Gal","year":"1999","journal-title":"Int Immunol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0300060513487642","article-title":"Indoleamine 2,3-dioxygenase levels at the normal and recurrent spontaneous abortion fetal-maternal interface","volume":"41","author":"Ban","year":"2013","journal-title":"J Int Med Res"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1095\/biolreprod.107.066324","article-title":"Expression and function of PDCD1 at the human maternal-fetal interface","volume":"79","author":"Taglauer","year":"2008","journal-title":"Biol Reprod"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1158\/1055-9965.EPI-14-0654","article-title":"Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type","volume":"23","author":"Gatalica","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.4049\/jimmunol.1002031","article-title":"The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance","volume":"187","author":"D\u2019Addio","year":"2011","journal-title":"J Immunol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1470-2045(07)70204-8","article-title":"Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets","volume":"8","author":"Shih Ie","year":"2007","journal-title":"Lancet Oncol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.placenta.2014.02.004","article-title":"Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells","volume":"35","author":"Alijotas-Reig","year":"2014","journal-title":"Placenta"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/0008-5472.CAN-15-2001","article-title":"Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNgamma That Induce PD-L1 Expression in Head and Neck Cancer","volume":"76","author":"Concha-Benavente","year":"2016","journal-title":"Cancer Res"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/gyno.2000.5777","article-title":"Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor","volume":"77","author":"Tuncer","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1095\/biolreprod.108.073353","article-title":"Interferon gamma in successful pregnancies","volume":"80","author":"Murphy","year":"2009","journal-title":"Biol Reprod"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/sji.12196","article-title":"Interaction of decidual CD56+ NK with trophoblast cells during normal pregnancy and recurrent spontaneous abortion at early term of gestation","volume":"80","author":"Sotnikova","year":"2014","journal-title":"Scand J Immunol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"e1008824","DOI":"10.1080\/2162402X.2015.1008824","article-title":"Interferon-gamma-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression","volume":"4","author":"Bellucci","year":"2015","journal-title":"Oncoimmunology"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0198-8859(00)00196-8","article-title":"HLA-G expression in trophoblast cells is independent of embryonic development","volume":"61","author":"Rabreau","year":"2000","journal-title":"Hum Immunol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2007.06.012","article-title":"Clinical and biological significance of HLA-G expression in ovarian cancer","volume":"17","author":"Sheu","year":"2007","journal-title":"Semin Cancer Biol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2015.00128","article-title":"HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche","volume":"6","author":"Gregori","year":"2015","journal-title":"Front Immunol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J Exp Med"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1073\/pnas.96.10.5674","article-title":"Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94\/NKG2A and acquire p49, an HLA-G1-specific receptor","volume":"96","author":"Ponte","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1038\/cddis.2015.112","article-title":"PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy","volume":"6","author":"Wang","year":"2015","journal-title":"Cell Death Dis"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201703000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:24:54Z","timestamp":1692840294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201703000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000305","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}